Lv1
40 积分 2026-02-20 加入
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
8小时前
已完结
Immunotherapies in chronic immune-mediated neuropathies
12天前
已完结
Pelvic congestion syndrome due to central venous outflow obstruction: A single‐center experience with may‐Thurner and nutcracker syndromes
21天前
已完结
皖公网安备34019202002308
